Brainstorm Cell Therapeutics reported $6.84M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Biogen BIIB:US USD 1.84B 650.7M
Brainstorm Cell Therapeutics BCLI:US USD 6.84M 750K
Cytokinetics CYTK:US USD 128.99M 4.22M
Gilead Sciences GILD:US USD 5.12B 917M
Halozyme Therapeutics HALO:US USD 106.99M 21.41M
Idera Pharmaceuticals IDRA:US USD 9.33M 3.96M